ORCID as entered in ROS
https://orcid.org/0000-0002-9885-8261
Select Publications
Conference Papers
, 2022, 'Laquinimod as a novel regulator of Kynurenine Pathway in Neural Stem Cells and Monocytes', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 39 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000939493200088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Laquinimod as a novel regulator of Kynurenine Pathway in Neural Stem Cells and Monocytes', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 39 - 40, presented at
, 2021, '032 Cognitive deficits are associated with anosmia but not anxio-depressive symptoms in COVID-19', in BMJ Neurology Open, BMJ, pp. a12 - a12, presented at
, 2020, 'Prospective study of magnetic resonance spectroscopy identifies specific metabolite changes in covert hepatic encephalopathy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 65 - 66, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'The kynurenine pathway of tryptophan metabolism is induced by interferon-gamma in human adipose stem cells', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, pp. NP35 - NP35, presented at
, 2019, 'The kynurenine pathway of tryptophan metabolism modulates mouse neural stem cell proliferation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, pp. NP3 - NP4, presented at
, 2019, 'Asthma and affective traits in adults: a genetically informative study', in EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society (ERS), SPAIN, Madrid, pp. pa2774, presented at
, 2019, 'Asthma and all-cause mortality in children and young adults - a Swedish population based study', in EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society (ERS), SPAIN, Madrid, pp. oa4972, presented at
, 2019, 'Effects of Diffusion MRI Model and Harmonization on the Consistency of Findings in an International Multi-cohort HIV Neuroimaging Study', in Mathematics and Visualization, pp. 203 - 215, http://dx.doi.org/10.1007/978-3-030-05831-9_17
, 2018, 'Combining supervised and unsupervised models to characterize asthma phenotypes in children', in EUROPEAN RESPIRATORY JOURNAL, European Respiratory Society (ERS), FRANCE, Paris, pp. pa4684, presented at
, 2018, 'Prescribed analgesics in pregnancy and the risk of child asthma- a register-based study.', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, FRANCE, Paris, presented at
, 2018, 'Academic achievement of adolescents with asthma and atopic diseases', in ALLERGY, WILEY, GERMANY, Munich, pp. 313 - 313, presented at
, 2017, 'Is there a genetic association between atopic disease and internalizing disorders in children?', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, ITALY, Milan, presented at
, 2016, 'LATE-BREAKING ABSTRACT: Maternal distress and childhood asthma. A Swedish registry study', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, http://dx.doi.org/10.1183/13993003.congress-2016.PA3137
, 2015, 'DECREASED CELLULAR ENERGY IN THE BRAIN FRONTAL WHITE MATTER IS ASSOCIATED WITH PAST IMMUNOSUPPRESION IN CHRONIC HIV INFECTION', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A73 - A74, http://dx.doi.org/10.1136/sextrans-2015-052270.196
, 2014, 'Involvement of the kynurenine pathway in human glioma pathophysiology', in PLoS ONE, http://dx.doi.org/10.1371/journal.pone.0112945
, 2013, 'Preventing Quinolinic Acid-Induced Toxicity in Oligodendrocytes with Antagonizing Monoclonal Antibodies and Kynurenine Pathway Inhibitors', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, JAPAN, Kyoto, pp. 959 - 960, presented at
, 2013, 'Moderate neurocognitive decline can be detected over a four-month period using the HIV-dementia scale', in JOURNAL OF NEUROVIROLOGY, SPRINGER, DC, Washington, pp. S51 - S51, presented at
, 2011, 'Involvement of the Kynurenine Pathway in Multiple Sclerosis Progression: the Link between Neuroinflammation and Neurodegeneration', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, pp. 534 - 535, presented at
, 2011, 'Potential Activity of Kynurenine Pathway Modulators for Multiple Sclerosis Targeted Therapeutics', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, pp. 535 - 535, presented at
, 2011, 'Mefloquine Treatment in Patients with Progressive Multifocal Leukoencephalopathy (PML)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, HI, Honolulu, pp. A28 - A28, presented at
, 2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, ITALY, Milan, pp. 22 - 23, presented at
, 2010, 'Neurotropic HIV-1 viruses induce the Kynurenine Pathway (KP) more effectively compared to non-neurotropic viruses in monocyte derived dendritic cells (MDDCs)', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, ITALY, Milan, pp. 43 - 43, presented at
, 2010, 'Frontal white matter and Posterior Cingulate abnormalities metabolite abnormalities in older and clinically stable HIV+ individuals', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 67 - 67, presented at
, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', in MOVEMENT DISORDERS, WILEY-LISS, FRANCE, Paris, pp. S425 - S425, presented at
, 2009, 'Altered Structural Conformation of the V3 Region between CSF Isolates from HAD and Non-HAD Individuals: Implications for Co-Receptor Usage', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, FL, Miami Beach, pp. 71 - 72, presented at
, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, FL, Miami Beach, pp. 19 - 19, presented at
, 2009, 'Mechanism for involvement of S-100 β in HIV associated dementia', in JOURNAL OF NEUROVIROLOGY, SPRINGER, FL, Miami Beach, pp. 72 - 72, presented at
, 2009, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, FL, Miami Beach, pp. 19 - 20, presented at
, 2009, 'Tissue-specific sequence alterations in the HIV-1 envelope favoring CCR5-usage contribute to persistence of dual-tropic virus in brain', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, FL, Miami Beach, pp. 31 - 32, presented at
, 2009, 'Design of a clinical trial of mefloquine in patients with progressive multifocal leukoencephalopathy', in Multiple Sclerosis, Arnold, London, England, pp. S87 - S87, presented at
, 2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P42 - P42
, 2008, 'Characterization of the kynurenine pathway in human primary neurons', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 78 - 78, presented at
, 2008, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P43 - P43, presented at
, 2007, 'Cerebrospinal fluid (CSF) soluble urokinase plasminogen activator (uPA) receptor (suPAR) in AIDS dementia complex, and its relationships with other uPA, virological, immuneactivation and neuronal CSF markers', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, CA, San Diego, pp. 6 - 6, presented at
, 2007, 'The kynurenine pathway metabolite quinolinic acid upregulates CCR5 expression', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, CA, San Diego, pp. 91 - 91, presented at
, 2007, 'S-100b: Role in the pathogenesis of HIV associated dementia (HAD)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, MA, Boston, pp. A140 - A140, presented at
, 2006, 'Variable benefit in neuropsychological function in HIV infected HAART-treated patients', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Diego, pp. A257 - A257, presented at
, 1997, 'Evidence for a paracrine growth-regulatory loop involving proximal tubule epithelial cells and cortical fibroblasts in the human kidney.', in KIDNEY INTERNATIONAL, BLACKWELL SCIENCE INC, pp. 1307 - 1307, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WP69600048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1997, 'Insulin-like growth factor-1 (IGF-I) stimulates apical sodium-hydrogen exchange (NHE) in human proximal tubule cells (PTC).', in KIDNEY INTERNATIONAL, BLACKWELL SCIENCE INC, pp. 1323 - 1323, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WP69600120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1997, 'Transport characteristics of human proximal tubule cells (PTC) in primary culture.', in KIDNEY INTERNATIONAL, BLACKWELL SCIENCE INC, pp. 1306 - 1306, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WP69600045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1997, 'AIDS dementia complex and its prevention', in Antiviral Therapy, Int Medical Press Ltd, London, England, pp. 69 - 73, presented at
, 1995, 'Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of B2microglobulin and neopterin', in Journal of Infectious Diseases, University of Chicago Press, Chicago, IL, presented at
, 1993, 'HIV-1-related neurological disease', in Journal of Acquired Immune Deficiency Syndromes, pp. S10 - S15
, 1991, 'Pursuit eye movement dysfunction in HIV-1 seropositive individuals.', in Journal of psychiatry & neuroscience : JPN, pp. 247 - 252
, 1989, 'CEREBROSPINAL-FLUID QUINOLINIC ACID AND KYNURENIC ACID IN HIV-1 INFECTION', in GUIDOTTI A (ed.), NEUROTOXICITY OF EXCITATORY AMINO ACIDS, RAVEN PRESS, AZ, SCOTTSDALE, pp. 217 - 221, presented at
Filter by type
https://orcid.org/0000-0002-9885-8261